|
Market Closed -
Nasdaq
23:00:00 02/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 2.710 USD | -1.81% |
|
-5.90% | +66.26% |
| 08-13 | Ovid Therapeutics Reports Pipeline and Business Updates | CI |
| 08-13 | Ovid Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OVID THERAPEUTICS INC. | Bio Therapeutic Drugs | -1.81% | -5.90% | +66.26% | +120.33% | -24.30% | 529M |  |  | |
- Stock Market
- Stocks
- OVID Stock
- Charts Ovid Therapeutics Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
